CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 243 enrolled
Drug / intervention
Relational Agent and heart rate and rhythm monitor +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04075994
NCT04075994N/ACompleted

A Mobile Relational Agent to Enhance Atrial Fibrillation Self-care

University of Pittsburgh·interventional·Posted Sep 3, 2019·Updated May 30, 2024

In Brief

A clinical study evaluating Relational Agent and heart rate and rhythm monitor and Usual Care for Atrial Fibrillation and 4 related conditions. Completed, enrolled 243 participants across 1 site.

Detailed Summary

Atrial fibrillation (AF) is a common, morbid condition with increasing prevalence. Poor health-related quality of life is common in AF. Patients experience debilitating symptoms and challenging adherence to long-term (possibly lifelong) anticoagulation. The increased risks of stroke, heart failure and mortality associated with AF persist even with optimal treatment. Morbidity in AF is further exacerbated by social factors. Limited health literacy carries challenges of learning a specialized terminology and navigating specialized treatments. In multiple cardiovascular diseases, self-care has demonstrated improvement in self-efficacy, health-related quality of life, symptom burden, and health care utilization - essential components of patient success with AF. Selfcare can provide the critical skills to navigate a challenging chronic disease and improve patient-centered outcomes. Delivery of self-care as a mobile health intervention can complement standard care with a longitudinal intervention to improve patient-centered strategies for AF. While self-care interventions for AF have focused foremost on self-monitoring of anticoagulation,self-care has demonstrated its potential to meet the "triple aim" of improved patient experience, reduced health care utilization, and lower costs.

Study Details

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 3, 2019
Enrollment StartJan 2, 2020
Primary CompletionApr 11, 2023
Study CompletionAug 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.8 years ago

Interventions

Relational Agent and heart rate and rhythm monitorbehavioral

Use of the Relational Agent and heart rate and rhythm monitor daily for 120 days.

Usual Carebehavioral

Use of the WebMD app and heart rate and rhythm monitor daily for 120 days.